Recently, Ventech China’s A round portfolio company E-Health Now, officially announced the completion of the B round of financing. This round of financing was led by Dongfang State-owned Assets, and previous investors such as Ventech China, GSR Ventures, Langrun Investment, and Tongji Alumni Fund continued to invest.

It is worth mentioning that since 2021, E-Health Now has successfully completed fundraising every year. In 2022, E-Health Now completed two consecutive rounds of financing. Now, E-Health Now has completed the B round of financing in less than a year since the last round of financing.

Among the investors, in addition to the new investment institution Dongfang State-owned Assets, the continuous investment from previous investors also reflects investors' confidence in E-Health Now. E-Health Now is indeed further strengthening the confidence of investors with the rapid development of its business.

Bring health management services to 25 million users

As a digital medical and health service platform, E-Health Now adopts the B2B2C model. By providing medical and health service solutions for commercial insurance, banks and enterprises, it is expected to reach 25 million customers in 2023 and provide them with health management services. At present, E-Health Now has cooperated with 80 financial insurance companies, 20 banks and medium and large enterprises.

Over the past period, E-Health Now has also further integrated other resources in the supply chain. Through the further expansion of coverage of pharmaceutical and device companies, testing institutions, etc., a deeper ecosystem layout will be realized. 

Based on this, E-Health Now has been able to provide customers with health assessment, health consultation, early disease screening, genetic testing, medical green notification, expert second consultation, domestic consultation, international multidisciplinary consultation, domestic special medicine, overseas special medicine, etc. 

Leverage AI to boost efficiency

AI is constantly developing in the medical and health ecosystem, in fields such as medical care and health, generative AI technology has begun to be gradually applied to various aspects such as medical image analysis, new drug research and development, clinical diagnosis and intelligent health management. It is foreseeable that with the expansion and innovation of artificial intelligence functions, it is very likely to open up new fields for clinicians and researchers, and provide new ideas and approaches for fields including genomics exploration, pharmaceutical research and development, and disease diagnosis. In the future, the combined application of artificial intelligence and medical treatment will undoubtedly have a huge opportunities.

After this round of financing, the CEO of E-Health Now, Ms. Xu also stated that while continuing to deepen its core barrier, the funds will be mainly used in the refined operation of health management services, that is, the upgrade of the AI digital medical and health service platform. For example, build digital doctors, further integrate artificial intelligence into the system to achieve deep integration, reduce costs and increase efficiency, improve user service experience and satisfaction.

Eric Huet, a Managing Partner of Ventech China, says: "The very impressive growth of E-Health Now even during the tough period shows that the company pointed exactly where healthcare is due to go. The company's rapid response to the market and corresponding management capabilities encourage us to believe that E-Health Now is growing into a company that will truly bring transformations to China's health management industry."